[1] Petruzziello A, et al. Epidemiology of hepatitis B virus (HBV) and hepatitis C virus (HCV) Related Hepatocellular Carcinoma.Open Virol J, 2018,12:26-32. [2] De Martel C, Maucort-Boulch D, Plummer M, et al. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma.Hepatology, 2015,62:1190-1200. [3] Zhou Y, Zhao Y, Gao Y, et al. Hepatitis C virus NS3 protein enhances hepatocellular carcinoma cell invasion by promoting PPM1A ubiquitination and degradation. J Exp Clin Cancer Res, 2017, 36:42 [4] Siavoshian S, Abraham JD, Kieny MP, et al. HCV core, NS3, NS5A and NS5B proteins modulate cell proliferation independently from p53 expression in hepatocarcinoma cell lines. Arch Virol,2004, 149: 323-336. [5] Healy CM, Cafferkey MT, Conroy A, et al.Outcome of infants born to hepatitis C infected women.Ir J Med Sci, 2001,170:103-106. [6] Irshad M, Gupta P, Irshad K.Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection.World J Hepatol, 2017,9:1305-1314. [7] Zhang J, Ishigaki Y, Takegami T. Hepatitis C virus NS3 protein modulates the biological behaviors of malignant hepatocytes by altering the expression of host cell microRNA. Mol Med Rep, 2015,12:5109-5115. [8] Sabri S, Idrees M, Rafique S, et al.Studies on the role of NS3 and NS5A non-structural genes of hepatitis C virus genotype 3a local isolates in apoptosis.Int J Infect Dis, 2014,25:38-44. [9] He QQ, Chen ZC, Xiao XX, et al.Mechanism of hepatocyte transformation by HCV NS3 using two-dimensional electrophoresis and mass spectrometry.Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2007,32:387-395. [10] Zemel R, Gerechet S, Greif H, et al. Cell transformation induced by hepatitis C virus?NS3?serine protease.J Viral Hepat, 2001,8:96-102. [11] Banerjee A, Ray RB, Ray R.Oncogenic potential of hepatitis C virus proteins.Viruses, 2010,2:2108-2133. [12] Kasprzak A, Adamek A, Przybyszewska W, et al. p21/Wafl/Cipl cellular expression in chronic long-lasting hepatitis C: correlation with HCV proteins (C, NS3, NS5A), other cell-cycle related proteins and selected clinical data. Folia Histochem Cytobiol, 2009, 47:385-394. [13] Zhu Z, Tran H, Mathahs MM, et al. HCV induces telomerase reverse transcriptase, increases its catalytic activity, and promotes caspase degradation in infected human hepatocytes. PLoS One, 2017, 12: e0166853. [14] Ludlow AT, Slusher AL, Sayed ME. Insights into Telomerase/hTERT Alternative Splicing Regulation Using Bioinformatics and Network Analysis in Cancer. Cancers (Basel), 2019,11. pii: E666. [15] Hannen R, Bartsch JW.Essential roles of telomerase reverse transcriptase hTERT in cancer stemness and metastasis. FEBS Lett, 2018,592:2023-2031. |